Ken Griffin And James Flynn Are Not Wasting Any Time Getting In On These New IPOs

The portfolio of initial projects for 8Point3 Energy Partners LP (NASDAQ:CAFD) includes four which are in association with First Solar, Inc. (NASDAQ:FSLR), three of which 8Point3 has 49% ownership of, and five being contributed by SunPower Corporation (NASDAQ:SPWR), which are wholly owned by 8Point3. The total capacity of these projects stands at 432MW. The sponsors also have sound experience in the field and are leaders in the industry. According to 8Point3 Energy Partners LP (NASDAQ:CAFD)’s prospectus, the two sponsors supplied 39% of the 18.1 GW of solar power capacity installed in the United States between 2005 and 2014, and in the context of the OECD, their contribution stood at 11% during the same period.

The future for 8Point3 Energy Partners LP (NASDAQ:CAFD) looks promising given the increasing global demand for energy. According to The Energy Information Administration, the OECD’s energy requirement is expected to surge by 34% between 2014 and 2040. This requires a corresponding increase in capacity of about 600 GW.

Moving on to Deerfield’s healthcare pick, Nivalis Therapeutics Inc (NASDAQ:NVLS), the fund was a prominent stakeholder of the company even when it was private, as Deerfield oft invests in and helps small, private healthcare companies develop their products and wade through the regulatory hurdles of having them tested and approved. The $220 million emerging growth company is developing a novel class of therapies for treating cystic fibrosis, a genetic disorder that mostly affects the lungs, but can also harm the pancreas, liver, kidneys, and intestines.  The disease has no known cure, and affects about 70,000 people worldwide.

Since only palliative therapies for the treatment of cystic fibrosis currently exist, Nivalis Therapeutics Inc (NASDAQ:NVLS) has virtually no competitors in the market. However, the company’s lead product candidate, N9115 is currently nearing the end of Phase 1b clinical testing, and therefore there is a considerable amount of risk associated with the stock. However, Deerfield Management seems undeterred.

There are no other known shareholders of either company at this time among the funds in our database.

Disclosure: None